96
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Increased matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio in smokers with airway hyperresponsiveness and accelerated lung function decline

, , , , , , , & show all
Pages 1135-1144 | Published online: 11 Apr 2018

References

  • Global Burden of Disease Study CGlobal, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013Lancet2015386999574380026063472
  • VogelmeierCFCrinerGJMartinezFJGlobal strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD Executive SummaryAm J Respir Crit Care Med2017195555758228128970
  • BarnesPJInflammatory mechanisms in patients with chronic obstructive pulmonary diseaseJ Allergy Clin Immunol20161381162727373322
  • ChungKFAdcockIMMultifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destructionEur Respir J20083161334135618515558
  • BchirSNasrHBBouchetSConcomitant elevations of MMP-9, NGAL, proMMP-9/NGAL and neutrophil elastase in serum of smokers with chronic obstructive pulmonary diseaseJ Cell Mol Med20172171280129128004483
  • de BoerWIHauCMvan SchadewijkAStolkJvan KriekenJHHiemstraPSExpression of epidermal growth factors and their receptors in the bronchial epithelium of subjects with chronic obstructive pulmonary diseaseAm J Clin Pathol2006125218419216393673
  • LeeSHLeeSHKimCHIncreased expression of vascular endothelial growth factor and hypoxia inducible factor-1alpha in lung tissue of patients with chronic bronchitisClin Biochem2014477–855255924463065
  • TashkinDPAltoseMDBleeckerERThe lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research GroupAm Rev Respir Dis19921452 pt 13013101736734
  • FrewAJKennedySMChan-YeungMMethacholine responsiveness, smoking, and atopy as risk factors for accelerated FEV1 decline in male working populationsAm Rev Respir Dis199214648788831416413
  • Garcia-GarciaJMHernandezJRMartinez-MunizMAAirways reactivity, atopy and bronchoalveolar lavage in male smokers with airflow obstructionRespiration19966341992048815965
  • NavratilovaZKolekVPetrekMMatrix metalloproteinases and their inhibitors in chronic obstructive pulmonary diseaseArch Immunol Ther Exp (Warsz)2016643177193
  • LoffekSSchillingOFranzkeCWSeries “matrix metalloproteinases in lung health and disease”: biological role of matrix metalloproteinases: a critical balanceEur Respir J201138119120821177845
  • RoachHIYamadaNCheungKSAssociation between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regionsArthritis Rheum200552103110312416200590
  • NakamaruYVuppusettyCWadaHA protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9FASEB J20092392810281919376817
  • GaoZYeJInhibition of transcriptional activity of c-JUN by SIRT1Biochem Biophys Res Commun2008376479379618823944
  • OhnishiKTakagiMKurokawaYSatomiSKonttinenYTMatrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysemaLab Invest1998789107710879759652
  • VignolaAMRiccobonoLMirabellaASputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitisAm J Respir Crit Care Med19981586194519509847290
  • RussellRECulpittSVDeMatosCRelease and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary diseaseAm J Respir Cell Mol Biol200226560260911970913
  • LimSRocheNOliverBGMattosWBarnesPJChungKFBalance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10Am J Respir Crit Care Med20001624 Pt 11355136011029344
  • VandenbrouckeREDejonckheereELibertCA therapeutic role for matrix metalloproteinase inhibitors in lung diseases?Eur Respir J20113851200121421659416
  • CulpittSVMaziakWLoukidisSNightingaleJAMatthewsJLBarnesPJEffect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19991605 Pt 11635163910556133
  • BarnesPJKinases as novel therapeutic targets in asthma and chronic obstructive pulmonary diseasePharmacol Rev201668378881527363440
  • WangXZhangHXSunBXCross-shift airway responses and long-term decline in FEV1 in cotton textile workersAm J Respir Crit Care Med2008177331632017975204
  • PopaVATS guidelines for methacholine and exercise challenge testingAm J Respir Crit Care Med20011631292293
  • WangCHLiuCYLinHCYuCTChungKFKuoHPIncreased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophagesEur Respir J19981148098159623681
  • KupermanASRikerJBThe variable effect of smoking on pulmonary functionChest19736356556604703618
  • TerzikhanNVerhammeKMHofmanAStrickerBHBrusselleGGLahousseLPrevalence and incidence of COPD in smokers and non-smokers: the Rotterdam StudyEur J Epidemiol201631878579226946425
  • LeiYGaoYChenJGLCCI1 rs37973: a potential genetic predictor of therapeutic response to inhaled corticosteroids in Chinese chronic obstructive pulmonary disease patientsSci Rep201774255228186150
  • TkacovaRDaiDLVonkJMAirway hyperresponsiveness in chronic obstructive pulmonary disease: a marker of asthma-chronic obstructive pulmonary disease overlap syndrome?J Allergy Clin Immunol2016138615711579.e1027345171
  • XuXRijckenBSchoutenJPWeissSTAirways responsiveness and development and remission of chronic respiratory symptoms in adultsLancet19973509089143114349371166
  • O’ConnorGTSparrowDWeissSTA prospective longitudinal study of methacholine airway responsiveness as a predictor of pulmonary-function decline: the Normative Aging StudyAm J Respir Crit Care Med1995152187927599868
  • WalkerPPHadcroftJCostelloRWCalverleyPMLung function changes following methacholine inhalation in COPDRespir Med2009103453554119081234
  • KolahianSShahbazfarAATayefi-NasrabadiHTiotropium effects on airway inflammatory events in the cat as an animal model for acute cigarette smoke-induced lung inflammationExp Lung Res201440627228724784973
  • ShimodaTObaseYKishikawaRIwanagaTInfluence of cigarette smoking on airway inflammation and inhaled corticosteroid treatment in patients with asthmaAllergy Asthma Proc20163745058
  • PostmaDSRabeKFThe asthma-COPD overlap syndromeN Engl J Med2015373131241124926398072
  • CockcroftDWDavisBEMechanisms of airway hyperresponsivenessJ Allergy Clin Immunol2006118355155916950269
  • AtkinsonJJLuteyBASuzukiYThe role of matrix metalloproteinase-9 in cigarette smoke-induced emphysemaAm J Respir Crit Care Med2011183787688421057003
  • LiFWiegmanCSeiffertJMEffects of N-acetylcysteine in ozone-induced chronic obstructive pulmonary disease modelPLoS One2013811e8078224260479
  • SwartzMATschumperlinDJKammRDDrazenJMMechanical stress is communicated between different cell types to elicit matrix remodelingProc Natl Acad Sci U S A200198116180618511353845
  • KrsticJSantibanezJFTransforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cellsScientific World Journal2014201452175424578639
  • GraingeCLLauLCWardJAEffect of bronchoconstriction on airway remodeling in asthmaN Engl J Med2011364212006201521612469
  • MatsumotoHNiimiATakemuraMRelationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthmaThorax200560427728115790981
  • HoshinoMNakamuraYSimJShimojoJIsogaiSBronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammationJ Allergy Clin Immunol199810257837889819295
  • OverbeekSABraberSKoelinkPJCigarette smoke-induced collagen destruction; key to chronic neutrophilic airway inflammation?PLoS One201381e5561223383243
  • GrzelaKLitwiniukMZagorskaWGrzelaTAirway remodeling in chronic obstructive pulmonary disease and asthma: the role of matrix metalloproteinase-9Arch Immunol Ther Exp (Warsz)20166414755
  • KochAGiembyczMStirlingRGEffect of smoking on MAP kinase-induced modulation of IL-8 in human alveolar macrophagesEur Respir J200423680581215218990
  • BhavsarPHewMKhorasaniNRelative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthmaThorax200863978479018492738
  • RendaTBaraldoSPelaiaGIncreased activation of p38 MAPK in COPDEur Respir J2008311626917959643
  • WangQMWangHLiYFInhibition of EMMPRIN and MMP-9 expression by epigallocatechin-3-gallate through 67-kDa laminin receptor in PMA-induced macrophagesCell Physiol Biochem20163962308231927832636
  • ZhouXGuDHouGErythromycin attenuates metalloprotease/anti-metalloprotease imbalance in cigarette smoke-induced emphysema in rats via the mitogen-activated protein kinase/nuclear factor-kappaB activation pathwayMol Med Rep20171552983299028358431
  • KimSEThanh ThuyTTLeeJHSimvastatin inhibits induction of matrix metalloproteinase-9 in rat alveolar macrophages exposed to cigarette smoke extractExp Mol Med200941427728719299917
  • NormanPInvestigational p38 inhibitors for the treatment of chronic obstructive pulmonary diseaseExpert Opin Investig Drugs2015243383392
  • HouGYinYHanDWangQYKangJRosiglitazone attenuates the metalloprotease/anti-metalloprotease imbalance in emphysema induced by cigarette smoke: involvement of extracellular signal-regulated kinase and NFkappaB signalingInt J Chron Obstruct Pulmon Dis20151071572425897215
  • NakamuraMWadaHHondaKClarithromycin ameliorates pulmonary inflammation induced by short term cigarette smoke exposure in micePulm Pharmacol Ther201535606626363279